362 Association of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with clinical outcomes to tislelizumab monotherapy in patients with previously treated advanced h... by Yong Liu, Richard Hubner, Ruiqi Huang, Yee Chao, Ying Cheng, Zhirong Shen, Xikun Wu, Congying Xie, Bai Li, Chen Ling, Philippe MERLE, Jane Margetts, Helena Verdaguer Mata, Cong Fei, Sandra Chica Duque, Zhenggang Ren

NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroen... by Mairéad G. McNamara, Jayne Swain, Zoe Craig, Rohini Sharma, Olusola Faluyi, Jonathan Wadsley, Carys Morgan, Lucy R. Wall, Ian Chau, Nick Reed, Debashis Sarker, Jane Margetts, Daniel Krell, Judith Cave, Sharmila Sothi, Alan Anthoney, Christopher Bell, Alkesh Patel, Jamie B. Oughton, David A. Cairns, Wasat Mansoor, Angela Lamarca, Richard A. Hubner, Juan W. Valle

Get full text

COVID-19 and liver cancer: lost patients and larger tumours by Helen L Reeves, Tim Hoare, Steven Masson, Paul Turner, Lucy Walker, Quentin M Anstee, Stuart McPherson, Mhairi Donnelly, Preya Patel, Beate Haugk, Antony Darne, John Scott, Robyn Watson, Jessica Dyson, Steven White, Gourab Sen, Sanjay Pandanaboyana, John Hammond, Stuart Robinson, Jeremy J French, Mark Hudson, Kirsty Anderson, Derek M Manas, Peter Littler, Daniel Geh, Misti McCain, Alastair Burt, Louise MacDougal, Michael McNeil, Nick Wadd, Syed Asghar, Lavanya Mariappan, Jane Margetts, Yvonne Bury, Shreya Raman, Daniel Parkinson, Benjamin Stenberg

Get full text